Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Mechanisms of Persistent Neurobiological Changes Following Adolescent Alcohol Exposure: NADIA Consortium Findings.

Crews FT, Robinson DL, Chandler LJ, Ehlers CL, Mulholland PJ, Pandey SC, Rodd ZA, Spear LP, Swartzwelder HS, Vetreno RP.

Alcohol Clin Exp Res. 2019 Jul 23. doi: 10.1111/acer.14154. [Epub ahead of print] Review.

PMID:
31335972
2.

A grounded theory of interprofessional learning and paramedic care.

Mulholland P, Barnett T, Woodroffe J.

J Interprof Care. 2019 Jul 22:1-10. doi: 10.1080/13561820.2019.1635095. [Epub ahead of print]

PMID:
31329003
3.

High-Resolution In Vivo Fundus Angiography using a Nonadaptive Optics Imaging System.

Okada M, Heeren TFC, Mulholland PJ, Maloca PM, Cilkova M, Rocco V, Fruttiger M, Egan CA, Anderson RS, Tufail A.

Transl Vis Sci Technol. 2019 Jun 27;8(3):54. doi: 10.1167/tvst.8.3.54. eCollection 2019 May.

4.

Dynamic c-Fos changes in mouse brain during acute and protracted withdrawal from chronic intermittent ethanol exposure and relapse drinking.

Smith RJ, Anderson RI, Haun HL, Mulholland PJ, Griffin WC 3rd, Lopez MF, Becker HC.

Addict Biol. 2019 Jul 9:e12804. doi: 10.1111/adb.12804. [Epub ahead of print]

PMID:
31288295
5.

Correction to: Chronic Alcohol, Intrinsic Excitability, and Potassium Channels: Neuroadaptations and Drinking Behavior.

Cannady R, Rinker JA, Nimitvilai S, Woodward JJ, Mulholland PJ.

Handb Exp Pharmacol. 2018;248:619. doi: 10.1007/164_2018_192.

PMID:
30810861
6.

Harnessing the immune system in glioblastoma.

Brown NF, Carter TJ, Ottaviani D, Mulholland P.

Br J Cancer. 2018 Nov;119(10):1171-1181. doi: 10.1038/s41416-018-0258-8. Epub 2018 Nov 5. Review.

7.

Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.

van den Bent MJ, Klein M, Smits M, Reijneveld JC, French PJ, Clement P, de Vos FYF, Wick A, Mulholland PJ, Taphoorn MJB, Lewis J, Weller M, Chinot OL, Kros JM, de Heer I, Verschuere T, Coens C, Golfinopoulos V, Gorlia T, Idbaih A.

Lancet Oncol. 2018 Sep;19(9):1170-1179. doi: 10.1016/S1470-2045(18)30362-0. Epub 2018 Aug 13.

PMID:
30115593
8.

Increasing Brain-Derived Neurotrophic Factor (BDNF) in medial prefrontal cortex selectively reduces excessive drinking in ethanol dependent mice.

Haun HL, Griffin WC, Lopez MF, Solomon MG, Mulholland PJ, Woodward JJ, McGinty JF, Ron D, Becker HC.

Neuropharmacology. 2018 Sep 15;140:35-42. doi: 10.1016/j.neuropharm.2018.07.031. Epub 2018 Jul 26.

PMID:
30056122
9.

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 Jun 29;16(1):179. doi: 10.1186/s12967-018-1552-1.

10.

Use of a Binocular Optical Coherence Tomography System to Evaluate Strabismus in Primary Position.

Chopra R, Mulholland PJ, Tailor VK, Anderson RS, Keane PA.

JAMA Ophthalmol. 2018 Jul 1;136(7):811-817. doi: 10.1001/jamaophthalmol.2018.1973.

11.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 May 29;16(1):142. doi: 10.1186/s12967-018-1507-6. Erratum in: J Transl Med. 2018 Jun 29;16(1):179.

12.

A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098.

Brown NF, Williams M, Arkenau HT, Fleming RA, Tolson J, Yan L, Zhang J, Swartz L, Singh R, Auger KR, Lenox L, Cox D, Lewis Y, Plisson C, Searle G, Saleem A, Blagden S, Mulholland P.

Neuro Oncol. 2018 Nov 12;20(12):1634-1642. doi: 10.1093/neuonc/noy078.

PMID:
29788497
13.

Identification and validation of midbrain Kcnq4 regulation of heavy alcohol consumption in rodents.

McGuier NS, Rinker JA, Cannady R, Fulmer DB, Jones SR, Hoffman M, Mulholland PJ.

Neuropharmacology. 2018 Aug;138:10-19. doi: 10.1016/j.neuropharm.2018.05.020. Epub 2018 May 25.

14.

Optimising the glaucoma signal/noise ratio by mapping changes in spatial summation with area-modulated perimetric stimuli.

Rountree L, Mulholland PJ, Anderson RS, Garway-Heath DF, Morgan JE, Redmond T.

Sci Rep. 2018 Feb 1;8(1):2172. doi: 10.1038/s41598-018-20480-4.

15.

Chronic Alcohol, Intrinsic Excitability, and Potassium Channels: Neuroadaptations and Drinking Behavior.

Cannady R, Rinker JA, Nimitvilai S, Woodward JJ, Mulholland PJ.

Handb Exp Pharmacol. 2018;248:311-343. doi: 10.1007/164_2017_90. Erratum in: Handb Exp Pharmacol. 2018;248:619.

PMID:
29374839
16.

Fucoidan Prolongs the Circulation Time of Dextran-Coated Iron Oxide Nanoparticles.

Abdollah MRA, Carter TJ, Jones C, Kalber TL, Rajkumar V, Tolner B, Gruettner C, Zaw-Thin M, Baguña Torres J, Ellis M, Robson M, Pedley RB, Mulholland P, T M de Rosales R, Chester KA.

ACS Nano. 2018 Feb 27;12(2):1156-1169. doi: 10.1021/acsnano.7b06734. Epub 2018 Jan 17.

PMID:
29341587
17.

Donepezil Reverses Dendritic Spine Morphology Adaptations and Fmr1 Epigenetic Modifications in Hippocampus of Adult Rats After Adolescent Alcohol Exposure.

Mulholland PJ, Teppen TL, Miller KM, Sexton HG, Pandey SC, Swartzwelder HS.

Alcohol Clin Exp Res. 2018 Apr;42(4):706-717. doi: 10.1111/acer.13599. Epub 2018 Feb 15.

18.

Dabrafenib and trametinib in BRAFV600E mutated glioma.

Brown NF, Carter T, Kitchen N, Mulholland P.

CNS Oncol. 2017 Oct;6(4):291-296. doi: 10.2217/cns-2017-0006. Epub 2017 Oct 6.

19.

Human Factor and Usability Testing of a Binocular Optical Coherence Tomography System.

Chopra R, Mulholland PJ, Dubis AM, Anderson RS, Keane PA.

Transl Vis Sci Technol. 2017 Aug 15;6(4):16. doi: 10.1167/tvst.6.4.16. eCollection 2017 Jul.

20.

Persistent cognitive and morphological alterations induced by repeated exposure of adolescent rats to the abused inhalant toluene.

Braunscheidel KM, Gass JT, Mulholland PJ, Floresco SB, Woodward JJ.

Neurobiol Learn Mem. 2017 Oct;144:136-146. doi: 10.1016/j.nlm.2017.07.007. Epub 2017 Jul 15.

21.

Probing the role of excited states in ionization of acetylene.

Dundas D, Mulholland P, Wardlow A, de la Calle A.

Phys Chem Chem Phys. 2017 Aug 2;19(30):19619-19630. doi: 10.1039/c7cp01661a.

PMID:
28429023
22.

Promising pharmacogenetic targets for treating alcohol use disorder: evidence from preclinical models.

Rinker JA, Mulholland PJ.

Pharmacogenomics. 2017 Apr;18(6):555-570. doi: 10.2217/pgs-2016-0193. Epub 2017 Mar 27. Review.

23.

Prefrontal Cortex KCa2 Channels Regulate mGlu5-Dependent Plasticity and Extinction of Alcohol-Seeking Behavior.

Cannady R, McGonigal JT, Newsom RJ, Woodward JJ, Mulholland PJ, Gass JT.

J Neurosci. 2017 Apr 19;37(16):4359-4369. doi: 10.1523/JNEUROSCI.2873-16.2017. Epub 2017 Mar 20.

24.

Effects of Repeated Ethanol Exposures on NMDA Receptor Expression and Locomotor Sensitization in Mice Expressing Ethanol Resistant NMDA Receptors.

den Hartog CR, Gilstrap M, Eaton B, Lench DH, Mulholland PJ, Homanics GE, Woodward JJ.

Front Neurosci. 2017 Feb 21;11:84. doi: 10.3389/fnins.2017.00084. eCollection 2017.

25.

Orbitofrontal Neuroadaptations and Cross-Species Synaptic Biomarkers in Heavy-Drinking Macaques.

Nimitvilai S, Uys JD, Woodward JJ, Randall PK, Ball LE, Williams RW, Jones BC, Lu L, Grant KA, Mulholland PJ.

J Neurosci. 2017 Mar 29;37(13):3646-3660. doi: 10.1523/JNEUROSCI.0133-17.2017. Epub 2017 Mar 7.

26.

Ethanol Dependence Abolishes Monoamine and GIRK (Kir3) Channel Inhibition of Orbitofrontal Cortex Excitability.

Nimitvilai S, Lopez MF, Mulholland PJ, Woodward JJ.

Neuropsychopharmacology. 2017 Aug;42(9):1800-1812. doi: 10.1038/npp.2017.22. Epub 2017 Jan 31.

27.

Adjuvant Chemotherapy is Indicated in Patients with Lower Grade Glioma.

Brown N, Carter T, Mulholland P.

Clin Oncol (R Coll Radiol). 2017 Mar;29(3):141-142. doi: 10.1016/j.clon.2016.11.006. Epub 2016 Dec 8. No abstract available.

PMID:
27939336
28.

Relationship between Psychophysical Measures of Retinal Ganglion Cell Density and In Vivo Measures of Cone Density in Glaucoma.

Matlach J, Mulholland PJ, Cilkova M, Chopra R, Shah N, Redmond T, Dakin SC, Garway-Heath DF, Anderson RS.

Ophthalmology. 2017 Mar;124(3):310-319. doi: 10.1016/j.ophtha.2016.10.029. Epub 2016 Dec 5.

PMID:
27932223
29.

p53 controls CDC7 levels to reinforce G1 cell cycle arrest upon genotoxic stress.

Tudzarova S, Mulholland P, Dey A, Stoeber K, Okorokov AL, Williams GH.

Cell Cycle. 2016 Nov;15(21):2958-2972. Epub 2016 Sep 9.

30.

Dabrafenib in BRAFV600-mutated anaplastic pleomorphic xanthoastrocytoma.

Brown NF, Carter T, Mulholland P.

CNS Oncol. 2017 Jan;6(1):5-9. doi: 10.2217/cns-2016-0031. Epub 2016 Oct 26.

31.

Kv7 channels in the nucleus accumbens are altered by chronic drinking and are targets for reducing alcohol consumption.

McGuier NS, Griffin WC 3rd, Gass JT, Padula AE, Chesler EJ, Mulholland PJ.

Addict Biol. 2016 Nov;21(6):1097-1112. doi: 10.1111/adb.12279. Epub 2015 Jun 23.

32.

Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis.

Bardella C, Al-Dalahmah O, Krell D, Brazauskas P, Al-Qahtani K, Tomkova M, Adam J, Serres S, Lockstone H, Freeman-Mills L, Pfeffer I, Sibson N, Goldin R, Schuster-Böeckler B, Pollard PJ, Soga T, McCullagh JS, Schofield CJ, Mulholland P, Ansorge O, Kriaucionis S, Ratcliffe PJ, Szele FG, Tomlinson I.

Cancer Cell. 2016 Oct 10;30(4):578-594. doi: 10.1016/j.ccell.2016.08.017. Epub 2016 Sep 29.

33.

Binge-Like Alcohol Exposure During Adolescence Disrupts Dopaminergic Neurotransmission in the Adult Prelimbic Cortex.

Trantham-Davidson H, Centanni SW, Garr SC, New NN, Mulholland PJ, Gass JT, Glover EJ, Floresco SB, Crews FT, Krishnan HR, Pandey SC, Chandler LJ.

Neuropsychopharmacology. 2017 Apr;42(5):1024-1036. doi: 10.1038/npp.2016.190. Epub 2016 Sep 13.

34.

Combining Ipilimumab and Bevacizumab in Glioblastoma: Is it Really Safe and Effective? Author Response.

Carter T, Shaw H, Mulholland P.

Clin Oncol (R Coll Radiol). 2016 Oct;28(10):664. doi: 10.1016/j.clon.2016.07.009. Epub 2016 Jul 27. No abstract available.

PMID:
27475288
35.

Differential potassium channel gene regulation in BXD mice reveals novel targets for pharmacogenetic therapies to reduce heavy alcohol drinking.

Rinker JA, Fulmer DB, Trantham-Davidson H, Smith ML, Williams RW, Lopez MF, Randall PK, Chandler LJ, Miles MF, Becker HC, Mulholland PJ.

Alcohol. 2017 Feb;58:33-45. doi: 10.1016/j.alcohol.2016.05.007. Epub 2016 Jun 27.

36.

Antibody-targeted nanoparticles for cancer treatment.

Carter T, Mulholland P, Chester K.

Immunotherapy. 2016 Jul;8(8):941-58. doi: 10.2217/imt.16.11. Review. Erratum in: Immunotherapy. 2016 Sep;8(9):1151.

PMID:
27381686
37.

Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma.

Brown N, McBain C, Nash S, Hopkins K, Sanghera P, Saran F, Phillips M, Dungey F, Clifton-Hadley L, Wanek K, Krell D, Jeffries S, Khan I, Smith P, Mulholland P.

PLoS One. 2016 May 27;11(5):e0156369. doi: 10.1371/journal.pone.0156369. eCollection 2016.

38.

A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma.

Rampling R, Peoples S, Mulholland PJ, James A, Al-Salihi O, Twelves CJ, McBain C, Jefferies S, Jackson A, Stewart W, Lindner J, Kutscher S, Hilf N, McGuigan L, Peters J, Hill K, Schoor O, Singh-Jasuja H, Halford SE, Ritchie JW.

Clin Cancer Res. 2016 Oct 1;22(19):4776-4785. Epub 2016 May 25.

39.

Signals from the Fourth Dimension Regulate Drug Relapse.

Mulholland PJ, Chandler LJ, Kalivas PW.

Trends Neurosci. 2016 Jul;39(7):472-485. doi: 10.1016/j.tins.2016.04.007. Epub 2016 May 10. Review.

40.

Ipilimumab and Bevacizumab in Glioblastoma.

Carter T, Shaw H, Cohn-Brown D, Chester K, Mulholland P.

Clin Oncol (R Coll Radiol). 2016 Oct;28(10):622-6. doi: 10.1016/j.clon.2016.04.042. Epub 2016 May 8.

41.

FMRP Mediates Chronic Ethanol-Induced Changes in NMDA, Kv4.2, and KChIP3 Expression in the Hippocampus.

Spencer KB, Mulholland PJ, Chandler LJ.

Alcohol Clin Exp Res. 2016 Jun;40(6):1251-61. doi: 10.1111/acer.13060. Epub 2016 May 5. Erratum in: Alcohol Clin Exp Res. 2016 Sep;40(9):2021.

42.

Spatiotemporal Summation of Perimetric Stimuli in Early Glaucoma.

Mulholland PJ, Redmond T, Garway-Heath DF, Zlatkova MB, Anderson RS.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6473-82. doi: 10.1167/iovs.15-16921.

PMID:
26447981
43.

The Effect of Age on the Temporal Summation of Achromatic Perimetric Stimuli.

Mulholland PJ, Redmond T, Garway-Heath DF, Zlatkova MB, Anderson RS.

Invest Ophthalmol Vis Sci. 2015 Oct;56(11):6467-72. doi: 10.1167/iovs.15-16920.

PMID:
26447980
44.

Effect of varying CRT refresh rate on the measurement of temporal summation.

Mulholland PJ, Zlatkova MB, Redmond T, Garway-Heath DF, Anderson RS.

Ophthalmic Physiol Opt. 2015 Sep;35(5):582-90. doi: 10.1111/opo.12227.

PMID:
26303451
45.

Chronic Intermittent Ethanol Exposure Enhances the Excitability and Synaptic Plasticity of Lateral Orbitofrontal Cortex Neurons and Induces a Tolerance to the Acute Inhibitory Actions of Ethanol.

Nimitvilai S, Lopez MF, Mulholland PJ, Woodward JJ.

Neuropsychopharmacology. 2016 Mar;41(4):1112-27. doi: 10.1038/npp.2015.250. Epub 2015 Aug 9.

46.

Resonantly Enhanced Multiphoton Ionization Spectrum of the Neutral Green Fluorescent Protein Chromophore.

Greenwood JB, Miles J, Camillis SD, Mulholland P, Zhang L, Parkes MA, Hailes HC, Fielding HH.

J Phys Chem Lett. 2014 Oct 16;5(20):3588-92. doi: 10.1021/jz5019256. Epub 2014 Oct 8.

PMID:
26278614
47.

Chronic intermittent ethanol induced axon and myelin degeneration is attenuated by calpain inhibition.

Samantaray S, Knaryan VH, Patel KS, Mulholland PJ, Becker HC, Banik NL.

Brain Res. 2015 Oct 5;1622:7-21. doi: 10.1016/j.brainres.2015.06.014. Epub 2015 Jun 20.

48.

Chronic intermittent ethanol exposure and withdrawal leads to adaptations in nucleus accumbens core postsynaptic density proteome and dendritic spines.

Uys JD, McGuier NS, Gass JT, Griffin WC 3rd, Ball LE, Mulholland PJ.

Addict Biol. 2016 May;21(3):560-74. doi: 10.1111/adb.12238. Epub 2015 Mar 17.

49.

Homer2 deletion alters dendritic spine morphology but not alcohol-associated adaptations in GluN2B-containing N-methyl-D-aspartate receptors in the nucleus accumbens.

McGuier NS, Padula AE, Mulholland PJ, Chandler LJ.

Front Pharmacol. 2015 Feb 23;6:28. doi: 10.3389/fphar.2015.00028. eCollection 2015.

50.

KCNN Genes that Encode Small-Conductance Ca2+-Activated K+ Channels Influence Alcohol and Drug Addiction.

Padula AE, Griffin WC 3rd, Lopez MF, Nimitvilai S, Cannady R, McGuier NS, Chesler EJ, Miles MF, Williams RW, Randall PK, Woodward JJ, Becker HC, Mulholland PJ.

Neuropsychopharmacology. 2015 Jul;40(8):1928-39. doi: 10.1038/npp.2015.42. Epub 2015 Feb 9.

Supplemental Content

Loading ...
Support Center